VA-MH BFT 2 SUBTEXT CLIN ADMIN CONTENT (6516)    REMINDER DIALOG (801.41)

• SEQUENCE:   5
  ITEM:   VA-MH BFT ED SCHIZOPHRENIA
• SEQUENCE:   50
  ITEM:   VA-MH BFT ED MOOD STABILIZERS
• SEQUENCE:   55
  ITEM:   VA-MH BFT ED ANTI-ANXIETY & SEDATIVE MEDS
• SEQUENCE:   60
  ITEM:   VA-MH BFT ED STRESS-VULNERABILITY MODEL
• SEQUENCE:   65
  ITEM:   VA-MH BFT ED CAREGIVERS GUIDE
• SEQUENCE:   70
  ITEM:   VA-MH BFT ED OTHER TOPIC
• SEQUENCE:   10
  ITEM:   VA-MH BFT ED SCHIZOAFFECTIVE DISORDER
• SEQUENCE:   15
  ITEM:   VA-MH BFT ED BIPOLAR
• SEQUENCE:   20
  ITEM:   VA-MH BFT ED MAJOR DEPRESSION
• SEQUENCE:   25
  ITEM:   VA-MH BFT ED PTSD
• SEQUENCE:   30
  ITEM:   VA-MH BFT ED OCD
• SEQUENCE:   35
  ITEM:   VA-MH BFT ED ETOH DRUG USE
• SEQUENCE:   40
  ITEM:   VA-MH BFT ED ANTIPSYCHOTIC MEDS
• SEQUENCE:   45
  ITEM:   VA-MH BFT ED ANTIDEPRESSANT MEDS

• EDIT DATE:   2014-12-01 15:45:47
  EDIT BY:   USER,SEVENTEEN
  EDIT COMMENTS:   

  Exchange Install
  

The clinician introduced the following topic(s) for the session. The 
topic(s) was/were: